Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) CEO Jeremy Bender Sells 7,873 Shares

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) CEO Jeremy Bender sold 7,873 shares of the business’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $16.08, for a total transaction of $126,597.84. Following the completion of the sale, the chief executive officer now […]

Related Keywords

Timessquare ,New York ,United States ,Piper Sandler ,Jeremy Bender ,York Mellon Corp ,Vanguard Group Inc ,Goldman Sachs Group ,York State Common Retirement Fund ,Timessquare Capital Management ,Needham Company ,Nasdaq ,Day One Biopharmaceuticals Company Profile ,Charles Schwab Investment Management Inc ,Day One Biopharmaceuticals Inc ,Day One Biopharmaceuticals ,Get Free Report ,One Biopharmaceuticals ,Schwab Investment Management ,New York Mellon Corp ,Square Capital Management ,Day One Biopharmaceuticals Daily ,